×
S&P 500   3,855.03 (+0.62%)
DOW   31,111.67 (+0.46%)
QQQ   290.69 (+1.30%)
AAPL   143.93 (+1.67%)
MSFT   267.84 (+1.90%)
META   170.86 (+1.59%)
GOOGL   2,309.83 (+1.97%)
AMZN   115.06 (+1.37%)
TSLA   699.84 (+0.09%)
NVDA   152.85 (+2.15%)
NIO   20.84 (-6.04%)
BABA   119.85 (-0.23%)
AMD   76.08 (+1.17%)
MU   57.92 (+2.10%)
CGC   2.68 (-1.11%)
T   21.19 (+0.09%)
GE   61.96 (-0.11%)
F   11.18 (-0.18%)
DIS   96.82 (-0.37%)
AMC   12.60 (-1.41%)
PFE   52.92 (+2.48%)
PYPL   73.94 (-0.62%)
NFLX   185.75 (-0.07%)
S&P 500   3,855.03 (+0.62%)
DOW   31,111.67 (+0.46%)
QQQ   290.69 (+1.30%)
AAPL   143.93 (+1.67%)
MSFT   267.84 (+1.90%)
META   170.86 (+1.59%)
GOOGL   2,309.83 (+1.97%)
AMZN   115.06 (+1.37%)
TSLA   699.84 (+0.09%)
NVDA   152.85 (+2.15%)
NIO   20.84 (-6.04%)
BABA   119.85 (-0.23%)
AMD   76.08 (+1.17%)
MU   57.92 (+2.10%)
CGC   2.68 (-1.11%)
T   21.19 (+0.09%)
GE   61.96 (-0.11%)
F   11.18 (-0.18%)
DIS   96.82 (-0.37%)
AMC   12.60 (-1.41%)
PFE   52.92 (+2.48%)
PYPL   73.94 (-0.62%)
NFLX   185.75 (-0.07%)
S&P 500   3,855.03 (+0.62%)
DOW   31,111.67 (+0.46%)
QQQ   290.69 (+1.30%)
AAPL   143.93 (+1.67%)
MSFT   267.84 (+1.90%)
META   170.86 (+1.59%)
GOOGL   2,309.83 (+1.97%)
AMZN   115.06 (+1.37%)
TSLA   699.84 (+0.09%)
NVDA   152.85 (+2.15%)
NIO   20.84 (-6.04%)
BABA   119.85 (-0.23%)
AMD   76.08 (+1.17%)
MU   57.92 (+2.10%)
CGC   2.68 (-1.11%)
T   21.19 (+0.09%)
GE   61.96 (-0.11%)
F   11.18 (-0.18%)
DIS   96.82 (-0.37%)
AMC   12.60 (-1.41%)
PFE   52.92 (+2.48%)
PYPL   73.94 (-0.62%)
NFLX   185.75 (-0.07%)
S&P 500   3,855.03 (+0.62%)
DOW   31,111.67 (+0.46%)
QQQ   290.69 (+1.30%)
AAPL   143.93 (+1.67%)
MSFT   267.84 (+1.90%)
META   170.86 (+1.59%)
GOOGL   2,309.83 (+1.97%)
AMZN   115.06 (+1.37%)
TSLA   699.84 (+0.09%)
NVDA   152.85 (+2.15%)
NIO   20.84 (-6.04%)
BABA   119.85 (-0.23%)
AMD   76.08 (+1.17%)
MU   57.92 (+2.10%)
CGC   2.68 (-1.11%)
T   21.19 (+0.09%)
GE   61.96 (-0.11%)
F   11.18 (-0.18%)
DIS   96.82 (-0.37%)
AMC   12.60 (-1.41%)
PFE   52.92 (+2.48%)
PYPL   73.94 (-0.62%)
NFLX   185.75 (-0.07%)
NYSE:CANO

Cano Health Earnings Date, Estimates & Call Transcripts (2022)

$5.58
+0.77 (+16.01%)
(As of 07/6/2022 03:31 PM ET)
Add
Compare
Today's Range
$4.91
$6.08
50-Day Range
$4.14
$6.03
52-Week Range
$3.81
$15.58
Volume
716,849 shs
Average Volume
4.12 million shs
Market Capitalization
$2.70 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.90

Earnings Summary

Upcoming
Earnings Date
Aug. 11Estimated
Actual EPS
(May. 9)
-$0.07 Beat By $0.03
Consensus EPS
(May. 9)
-$0.10
Skip Charts & View Estimated and Actual Earnings Data

CANO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CANO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cano Health Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20221($0.02)($0.02)($0.02) 
Q2 20222($0.02)$0.02$0.00 
Q3 20222($0.03)$0.05$0.01 
Q4 20222($0.03)$0.08$0.03 
FY 20227($0.10)$0.13$0.02 
Q1 20231($0.02)($0.02)($0.02) 
Q2 20231($0.02)($0.02)($0.02) 
Q3 20231($0.02)($0.02)($0.02) 
Q4 20231($0.03)($0.03)($0.03) 
FY 20234($0.09)($0.09) ($0.09)

CANO Earnings Date and Information

Cano Health last posted its quarterly earnings results on May 9th, 2022. The reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.03. The firm had revenue of $704.34 million for the quarter, compared to analyst estimates of $676.10 million. Cano Health has generated ($0.28) earnings per share over the last year (($0.28) diluted earnings per share). Earnings for Cano Health are expected to grow in the coming year, from ($0.14) to ($0.01) per share. Cano Health has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off prior year's report dates.

Cano Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/11/2022
(Estimated)
        
5/9/2022Q1 2022($0.10)($0.07)+$0.03($0.14)$676.10 million$704.34 million
3/14/2022Q4 2021($0.01)($0.12)($0.11)($0.12)$524.88 million$492.26 million
11/9/2021Q3 2021($0.01)($0.02)($0.01)$0.05$455.61 million$526.80 million
8/12/2021Q2 2021($0.22)($0.22)($0.37)$393.16 million












Cano Health Earnings - Frequently Asked Questions

When is Cano Health's earnings date?

Cano Health has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off last year's report dates. Learn more on CANO's earnings history.

Did Cano Health beat their earnings estimates last quarter?

In the previous quarter, Cano Health (NYSE:CANO) reported ($0.07) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.10) by $0.03. Learn more on analysts' earnings estimate vs. CANO's actual earnings.

How much revenue does Cano Health generate each year?

Cano Health (NYSE:CANO) has a recorded annual revenue of $1.61 billion.

How much profit does Cano Health generate each year?

Cano Health (NYSE:CANO) has a recorded net income of -$18.02 million. CANO has generated -$0.28 earnings per share over the last four quarters.

What is Cano Health's EPS forecast for next year?

Cano Health's earnings are expected to grow from ($0.14) per share to ($0.01) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NYSE:CANO) was last updated on 7/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.